Category: Uncategorized

COVID-19 Response Plan

Luina Bio COVID 19 response plan

18 March 2020

Following the recent developments of the COVID 19 pandemic, the management team at Luina Bio has developed a series of new rules and actions that is targeted at protecting your health, decreasing the chances of viral transmission within the workplace and ensure business continuity during these challenging times. Prevention We… Read more
Extracting and Purifying Natural Products

Extracting and Purifying Natural Products

17 February 2020

A leading Australian contract development and manufacturing organisation, Luina Bio offers a range of capabilities in natural products extraction, purification and characterisation  A "natural product" is a chemical compound or substance produced by a living organism. Natural products provide an unparalleled source of chemical diversity for the discovery of valuable… Read more
What is API Manufacturing

What is API Contract Manufacturing?

17 February 2020

Partnering with the right contractor is one of the most critical decisions a pharmaceutical company can make  The active pharmaceutical ingredient (API) is the foundation of a final drug product and is a crucial consideration when choosing a Contract Development and Manufacturing Organisation (CDMO). To understand API contract manufacturing, first,… Read more
How Microbial Fermentation and Protein Biomanufacturing Works

How Microbial Fermentation and Protein Biomanufacturing Works

17 February 2020

Luina Bio’s manufacturing facility offers the latest fermentation technologies supported by world-renowned expertise in drug development and production      Microbial fermentation is the basis for the production of a wide variety of pharmaceutical drugs and biologics, from anti-cancer drugs and vaccines to hormonal disorder therapies and many others. Over the… Read more

LNC Therapeutics chooses LUINA BIO for the development and GMP manufacturing of its first Live…

22 October 2019

LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery have signed a manufacturing agreement with Luina Bio as the CDMO responsible for the development and manufacturing activities of a pharmaceutical development project aiming at harnessing the potential of Christensenella minuta (C.minuta) as a novel therapy to treating… Read more

2019 Premier of Queensland’s Export Awards Winners Announced

14 October 2019

Congratulations to all the 2019 Premier of Queensland's Export Awards category award winners last week. The 2019 awards drew nominations from all over Queensland, with 44 leading export businesses named as finalists in the lead up to the gala event. The QLD Export awards celebrates their thirtieth anniversary of the… Read more

In the News: Luina Bio: Growing impressively

2 September 2019

Published in The Australian Business Executive, read or listen to the interview with Managing Director Les Tillack as he leads the company’s innovation and committed pursuit of world-leading contract manufacturing. https://www.youtube.com/watch?v=g1FgtrGUbho Read more

Dyadic Announces Sub-Licensing Agreement with Luina Bio

30 April 2019

Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs and other biologic products, at flexible commercial scales, is pleased to announce… Read more
Luina Bio Export Awards

Luina Bio was awarded the QLD Export Award for Health & Biotechnology

9 November 2017

19 October 17, Congratulations to Luina Bio! Luina Bio was awarded the QLD Export Award for Health & Biotechnology. Presenting the awards were the Honourable Annastacia Palaszczuk MP, Premier of Queensland and Minister for the Arts, and the Honourable Curtis Pitt MP, Treasurer and Minister for Trade and Investment. “Queensland’s… Read more

LUINA BIO AND QUEENSLAND GOVERNMENT INVEST IN FUTURE OF ADVANCED MANUFACTURING

27 October 2017

Brisbane, Queensland, Australia – 27 October 2017 One of Australia’s leading biopharmaceutical manufacturing companies, Luina Bio, is today pleased to announce it has received a $405,000 “Made in Queensland” (MIQ) grant from the Queensland Government. The MIQ program is an important initiative within the Queensland Government’s $200 million Jobs and… Read more